Topics:
Hematologic Malignancies • Radiation Oncology
What RT fields would you recommend for a patient with early-stage diffuse large B-cell lymphoma who refuses or is unfit for systemic therapy?
Would you treat the involved site or involved field for definitive intent?
Answer from: Radiation Oncologist at Academic Institution
For a patient with stage I DLBCL, RT fields should encompass the involved site with a generous margin, the latter not precisely defined but dependent on what the site is and what side effects need to be considered with larger volumes. RT fields should not change much if the patient is not receiving ...
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
If no chemotherapy at all, I would consider involved-field radiation (IFRT), at least for the initial dose. For aggressive lymphoma, I feel it is safer to cover the entire lymphatic region. This is probably similar to the answers given by Dr. @Leonard Prosnitz and Dr. @Theodore E. Yaeger.